Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a 4.553% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a.) CCCN1C(=O)C(O)(c2c(C)[nH]c3ccccc23)c2ccccc21
b.) CC(C)CN1C(=O)c2ccccc2C1(O)Cc1ccccc1
Answer: a. CCCN1C(=O)C(O)(c2c(C)[nH]c3ccccc23)c2ccccc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCN1C(=O)C(O)(c2c(C)[nH]c3ccccc23)c2ccccc21
CCCN1C(=O)C(O)(c2c(C)[nH]c3ccccc23)c2ccccc21
3-hydroxy-3-(2-methyl-1H-indol-3-yl)-1-propylindol-2-one